shine-logo

Healthier

Home » Healthier

Radiopharm Theranostics and SHINE Technologies Announce Clinical Supply Agreement for Cancer-Fighting Medical Isotope

SHINE to supply n.c.a. lutetium-177 for the clinical development of [...]

2022-09-20T09:07:05-05:00September 20, 2022|Safer, Healthier, News, News Releases, 2022|

Visit Us at the SNMMI Annual Meeting 2022

The SHINE Technologies team is gearing up for this year’s SNMMI Annual Meeting, June 11-14 in Vancouver, British Columbia. Leading molecular-imaging and nuclear-medicine professionals from every corner of the industry will come together to share in-depth views of the latest research and development, as well as share insights into practical clinical applications. 

2022-09-08T09:07:38-05:00June 10, 2022|Healthier, Blog, 2022|

SHINE Announces Chris Vessell as General Manager of Therapeutics Division

JANESVILLE, Wis., May 23, 2022 – SHINE Technologies, LLC (SHINE), a next-generation nuclear technology company, today announced Chris Vessell has joined as General Manager of the Therapeutics Division. In this role, he will be responsible for developing and building the team dedicated to SHINE’s strategy and offerings around non-carrier-added lutetium-177 for cancer therapies.

2022-09-08T09:07:21-05:00May 23, 2022|Healthier, News, News Releases, Therapeutics, 2022|
Go to Top